Amgen Inc. (NASDAQ: AMGN) reported second quarter 2019 adjusted EPS of $3.97 on revenue of $5.9 billion. Analysts had predicted the biotechnology firm to post earnings of $3.59 per share on revenue of $5.68 billion. Amgen stock advanced about 1% during the after-hours.
“With our newer products generating strong volume gains globally and many first-in-class medicines advancing through our pipeline, we are well positioned to serve patients and deliver long-term growth for our shareholders,” said CEO Robert Bradway.
Related: Advaxis’ revenue declines in Q2 as Amgen terminaties collaboration agreement
For full-year 2019, Amgen lifted its lower end of revenue outlook. The company now expects revenue to be in the range of $22.4 billion to $22.9 billion versus the prior estimaate of $22 billion to $22.9 billion.
FY19 GAAP earnings per share outlook revised to $12.10-$12.71 versus the prior outlook of $11.68-12.73 per share. The company also lifted its lower end of adjusted EPS outlook to a range of $13.75-14.30 from the earlier forecast of $13.25-14.30 per share.
While peers Pfizer (NYSE: PFE) reported its second quarter results yesterday, Eli Lilly (NYSE: LLY) and Merck (NYSE: MRK) reported their Q2 earnings results today morning. While Pfizer’s results failed to impress the market, Eli Lilly’s Q2 profit beat estimates. Merck’s second quarter results were far ahead of analysts’ expectations.
Amgen stock had given a negative return of 9% since the beginning of this year and dropped 8% in the trailing 12 months.
Most Popular
Broadcom (AVGO) reports higher Q3 revenue and profit; results beat estimates
Semiconductor company Broadcom, Inc. (NASDAQ: AVGO) reported higher revenues and adjusted earnings for the third quarter of 2024 amid continued strong demand. The Q3 numbers also topped expectations. Earnings, excluding
Key takeaways from Hewlett Packard’s (HPE) Q3 2024 earnings report
Hewlett Packard Enterprise (NYSE: HPE) has delivered stronger-than-expected third-quarter results amid significant conversion in AI system revenues. The prospects for the company's AI server and edge computing businesses look promising
Hormel Foods (HRL): Factors that put a damper on the food company’s Q3 performance
Shares of Hormel Foods Corporation (NYSE: HRL) were up over 2% on Thursday. The stock is recovering from a fall it took a day ago after the company delivered mixed